Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Biochemical Society Transactions
|
January 28, 2020
Fragments: where are we now?
James Osborne, Stanislava Panova, Magdalini Rapti, et al.
Chemical Society Reviews
|
October 14, 2004
High-throughput protein crystallography and drug discovery
Ian Tickle, Andrew Sharff, Mladen Vinkovic, et al.
Nature
|
June 13, 2003
Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B
Rob L M van Montfort, Miles Congreve, Dominic Tisi, et al.
Nature Reviews. Drug Discovery
|
July 16, 2016
Twenty years on: the impact of fragments on drug discovery
Daniel A Erlanson, Stephen W Fesik, Roderick E Hubbard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2015
Detection of secondary binding sites in proteins using fragment screening
R Frederick Ludlow, Marcel L Verdonk, Harpreet K Saini, et al.
Journal of Medicinal Chemistry
|
January 22, 2005
Fragment-based lead discovery using X-ray crystallography
Michael J Hartshorn, Christopher W Murray, Anne Cleasby, et al.
Nature
|
July 16, 2003
Crystal structure of human cytochrome P450 2C9 with bound warfarin
Pamela A Williams, Jose Cosme, Alison Ward, et al.
Drug Discovery Today
|
December 27, 2019
Fragment-based drug discovery using cryo-EM
Michael Saur, Michael J Hartshorn, Jing Dong, et al.
Angewandte Chemie (International Ed. in English)
|
October 2, 2003
Detection of ligands from a dynamic combinatorial library by X-ray crystallography
Miles S Congreve, Deborah J Davis, Lindsay Devine, et al.
Chemmedchem
|
August 12, 2006
Automated protein-ligand crystallography for structure-based drug design
Wijnand T M Mooij, Michael J Hartshorn, Ian J Tickle, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Biochemical Society Transactions
|
January 28, 2020
Fragments: where are we now?
James Osborne, Stanislava Panova, Magdalini Rapti, et al.
Chemical Society Reviews
|
October 14, 2004
High-throughput protein crystallography and drug discovery
Ian Tickle, Andrew Sharff, Mladen Vinkovic, et al.
Nature
|
June 13, 2003
Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B
Rob L M van Montfort, Miles Congreve, Dominic Tisi, et al.
Nature Reviews. Drug Discovery
|
July 16, 2016
Twenty years on: the impact of fragments on drug discovery
Daniel A Erlanson, Stephen W Fesik, Roderick E Hubbard, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2015
Detection of secondary binding sites in proteins using fragment screening
R Frederick Ludlow, Marcel L Verdonk, Harpreet K Saini, et al.
Journal of Medicinal Chemistry
|
January 22, 2005
Fragment-based lead discovery using X-ray crystallography
Michael J Hartshorn, Christopher W Murray, Anne Cleasby, et al.
Nature
|
July 16, 2003
Crystal structure of human cytochrome P450 2C9 with bound warfarin
Pamela A Williams, Jose Cosme, Alison Ward, et al.
Drug Discovery Today
|
December 27, 2019
Fragment-based drug discovery using cryo-EM
Michael Saur, Michael J Hartshorn, Jing Dong, et al.
Angewandte Chemie (International Ed. in English)
|
October 2, 2003
Detection of ligands from a dynamic combinatorial library by X-ray crystallography
Miles S Congreve, Deborah J Davis, Lindsay Devine, et al.
Chemmedchem
|
August 12, 2006
Automated protein-ligand crystallography for structure-based drug design
Wijnand T M Mooij, Michael J Hartshorn, Ian J Tickle, et al.
Page
of 3